KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Prepaid Assets (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Prepaid Assets for 16 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 32.66% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 32.66% year-over-year, with the annual reading at $1.5 million for FY2025, 32.66% down from the prior year.
  • Prepaid Assets hit $1.5 million in Q4 2025 for Arbutus Biopharma, down from $2.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.9 million in Q1 2022 to a low of $1.5 million in Q4 2025.
  • Historically, Prepaid Assets has averaged $3.9 million across 5 years, with a median of $3.9 million in 2021.
  • Biggest five-year swings in Prepaid Assets: soared 85.74% in 2021 and later tumbled 46.23% in 2024.
  • Year by year, Prepaid Assets stood at $4.4 million in 2021, then crashed by 35.34% to $2.9 million in 2022, then soared by 47.81% to $4.2 million in 2023, then tumbled by 46.23% to $2.3 million in 2024, then crashed by 32.66% to $1.5 million in 2025.
  • Business Quant data shows Prepaid Assets for ABUS at $1.5 million in Q4 2025, $2.8 million in Q3 2025, and $4.0 million in Q2 2025.